Table 3 Baseline characteristics of patients included in the INPULSIS® pooled data set, experiencing no acute exacerbations or experiencing ≥ 1 acute exacerbation (analysis 2)
No acute exacerbations (n = 998) | ≥ 1 acute exacerbation (n = 63) | |
|---|---|---|
Women, n (%) | 209 (20.9) | 11 (17.5) |
Age, years | 66.6 (8.0) | 69.3 (7.5) |
Time since IPF diagnosis, years | 1.6 (1.3) | 1.8 (1.4) |
Ethnicity, n (%) | ||
White | 578 (57.9) | 30 (47.6) |
Black | 2 (0.2) | 0 (0) |
Asian | 304 (30.5) | 18 (28.6) |
Missing | 114 (11.4) | 15 (23.8) |
BMI, kg/m2 | 28.0 (4.6) | 27.1 (4.1) |
Smoking history, n (%) | ||
Non-smoker | 281 (28.2) | 15 (23.8) |
Ex-smoker | 670 (67.1) | 48 (76.2) |
Current smoker | 47 (4.7) | 0 (0) |
Comorbidities, n (%) | ||
PH | 30 (3.0) | 0 (0) |
COPD | 25 (2.5) | 2 (3.2) |
Lung cancera | 4 (0.4) | 0 (0) |
GERD | 231 (23.1) | 17 (27.0) |
CAD | 85 (8.5) | 3 (4.8) |
FVC, % predicted | 80.2 (17.8) | 69.4 (15.0) |
FEV1/FVC ratio | 81.5 (5.9) | 84.2 (5.5) |
DLCO, % predicted | 47.5 (13.3) | 42.6 (15.2) |